Development of Bet v 1-specific DNA aptamers for quality control of birch pollen extracts

被引：0
|
作者：
Bethanis, A. [1 ]
Ferreira, F. [1 ]
Aglas, L. [1 ]
机构：
[1] Univ Salzburg, Dept Biosci, Salzburg, Austria
来源：
ALLERGY | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0133
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [11] The diversity of Bet v 1-specific IgG4 antibodies remains mostly constant during the course of birch pollen immunotherapy
    Subbarayal, Brinda
    Schiller, Dirk
    Moebs, Christian
    Pfuetzner, Wolfgang
    Jahn-Schmid, Beatrice
    Gepp, Barbara
    Breiteneder, Heimo
    Vieths, Stefan
    Bohle, Barbara
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (06) : 1680 - 1682
  • [12] Detection of Bet v 1-specific IgG-producing cells in birch pollen-allergic patients and healthy controls by ELISPOT analysis
    Baum, C.
    Moebs, C.
    Pfuetzner, W.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (03) : E2 - E2
  • [13] Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis
    Keen, C
    Johansson, S
    Reinholdt, J
    Benson, M
    Wennergren, G
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2005, 16 (03) : 209 - 216
  • [14] Vaccination with carrier-bound peptides from the major birch pollen allergen Bet v 1 lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses
    Linhart, B.
    Focke-Tejkl, M.
    Valenta, R.
    IMMUNOLOGY, 2012, 137 : 462 - 463
  • [15] Bioavailability of the major birch pollen allergen Bet v 1
    Ochs, S
    Wallmuth, A
    Kasche, A
    Weichenmeier, I
    Traidl-Hoffmann, C
    Huss-Marp, J
    Krämer, U
    Link, E
    Gebauer, G
    Schober, W
    Behrendt, H
    Buters, JTM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 134 - 134
  • [16] Crossreactivity and T-cell epitope specificity of Bet v 1-specific T cells suggest the involvement of multiple isoallergens in sensitization to birch pollen
    Sparholt, SH
    Larsen, JN
    Ipsen, H
    Schou, C
    vanNeerven, RJJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 1997, 27 (08): : 932 - 941
  • [17] Recombinant birch allergens (Bet v 1 and Bet v 2) and the oral allergy syndrome in patients allergic to birch pollen
    De Amici, M
    Mosca, M
    Vignini, M
    Quaglini, S
    Moratti, R
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (05) : 490 - 492
  • [18] Bet v 1-specific IgE-, IgG1- and IgG4-antibody responses after immunotherapy with hypoallergenic rBet v1 or birch pollen extract
    Fiebig, H.
    Weber, B.
    Narkus, A.
    Cromwell, O.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S141 - S141
  • [19] Recombinant Bet v 1 vaccine for treatment of allergy to birch pollen
    Gronlund, Hans
    Gafvelin, Guro
    HUMAN VACCINES, 2010, 6 (12): : 970 - 977
  • [20] The History and Science of the Major Birch Pollen Allergen Bet v 1
    Breiteneder, Heimo
    Kraft, Dietrich
    BIOMOLECULES, 2023, 13 (07)
12345